Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yann Joly

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
Medecine Sciences : M/S|December 3, 2009
[Open source biotechnology: synopsis of a meeting of two revolutions]Yann Joly
Nature Biotechnology|May 12, 2010
Open biotechnology: licenses neededYann Joly
European Journal of Human Genetics : EJHG|September 27, 2022
Genetic discrimination still casts a large shadow in 2022Yann Joly, Gratien Dalpe
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|December 14, 2007
Currents in contemporary ethics. The tuberculosis scare in retrospectYann Joly, Gillian Nycum
European Journal of Human Genetics : EJHG|November 6, 2022
Correction: Genetic discrimination still casts a large shadow in 2022Yann Joly, Gratien Dalpe
Current Pharmacogenomics and Personalized Medicine|July 26, 2013
Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics SagaDerek So, Yann Joly
Life Sciences, Society and Policy|August 2, 2018
Clinical exome sequencing in France and Quebec: what are the challenges? What does the future hold?Gabrielle Bertier, Yann Joly
Paediatric Drugs|August 30, 2008
Improved understanding of genetic and genomic influences on drug disposition and action : implications for childrenDenise Avard, Yann Joly
Drug Development Research|September 9, 2014
Opportunities and challenges provided by cloud repositories for bioinformatics-enabled drug discoveryGratien Dalpé, Yann Joly
Journal of Law and the Biosciences|June 8, 2026
Still invisible? Legal and ethical treatment of intersex individuals in ChinaMeng Wang, Yann Joly
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
Medecine Sciences : M/S|December 3, 2009
[Open source biotechnology: synopsis of a meeting of two revolutions]Yann Joly
Nature Biotechnology|May 12, 2010
Open biotechnology: licenses neededYann Joly
European Journal of Human Genetics : EJHG|September 27, 2022
Genetic discrimination still casts a large shadow in 2022Yann Joly, Gratien Dalpe
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|December 14, 2007
Currents in contemporary ethics. The tuberculosis scare in retrospectYann Joly, Gillian Nycum
European Journal of Human Genetics : EJHG|November 6, 2022
Correction: Genetic discrimination still casts a large shadow in 2022Yann Joly, Gratien Dalpe
Current Pharmacogenomics and Personalized Medicine|July 26, 2013
Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics SagaDerek So, Yann Joly
Life Sciences, Society and Policy|August 2, 2018
Clinical exome sequencing in France and Quebec: what are the challenges? What does the future hold?Gabrielle Bertier, Yann Joly
Paediatric Drugs|August 30, 2008
Improved understanding of genetic and genomic influences on drug disposition and action : implications for childrenDenise Avard, Yann Joly
Drug Development Research|September 9, 2014
Opportunities and challenges provided by cloud repositories for bioinformatics-enabled drug discoveryGratien Dalpé, Yann Joly
Journal of Law and the Biosciences|June 8, 2026
Still invisible? Legal and ethical treatment of intersex individuals in ChinaMeng Wang, Yann Joly
Pageof 18